市監局要求壓實平臺和藥品經營企業主體責任 阿裏健康及京東健康作迴應
國家市場監管總局發佈《藥品網絡銷售監督管理辦法》,自12月起施行。市監總局要求壓實藥品網絡銷售平臺,責任明確從事藥品網絡銷售的藥品經營企業主體資格和要求,並依法明確疫苗、血液製品、精神藥品等國家實行特殊管理的藥品不得在網絡上銷售。
市監總局表示,明確對處方藥網絡銷售實行實名制,並按規定進行處方審覈調配,要求處方藥銷售前應當向消費者充分告知相關風險警示信息並經消費者確認知情。平臺與藥品網絡銷售企業簽訂協議,明確雙方藥品質素安全責任,規定平臺應當履行審覈、檢查監控以及發現嚴重違法行爲的停止服務和報告等義務。
據內媒報道,阿裏健康(00241.HK)迴應網售新規時表示,將提供更加明確的合規指引和要求。京東健康(06618.HK)迴應表示,已搭建自營藥品及器械質素合規管理體系 。(ta/w)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.